NFκBiz protein downregulation in acute kidney injury: Modulation of inflammation and survival in tubular cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 4, 2016, Pages 635-646

  Poveda, Jonay ^a   Sanz, Ana B ^a   Rayego Mateos, Sandra ^a   Ruiz Ortega, Marta ^a   Carrasco, Susana ^a   Ortiz, Alberto ^a   Sanchez Niño, Maria D ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Acute kidney injury; Apoptosis; Inflammation; NF B; TNF; Transcription factor; Tweak

Indexed keywords

FOLIC ACID; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TWEAK PROTEIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; IMMUNOMODULATION; INFLAMMATION; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTOMICS; UPREGULATION;

EID: 84958225926     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.01.006     Document Type: Article

References (52)

1. Chawla L.S., Kimmel P.L. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 2012, 82:516.
2. Bellomo R., Kellum J.A., Ronco C. Acute kidney injury. Lancet 2012, 380:756.
3. Remuzzi G., Ruggenenti P., Benigni A. Understanding the nature of renal disease progression. Kidney Int. 1997, 51:2.
4. van K.C., Daha M.R., Es L.A.v. Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory processes. Exp. Nephrol. 1999, 7:429.
5. Linkermann A., Chen G., Dong G., Kunzendorf U., Krautwald S., Dong Z. Regulated cell death in AKI. J. Am. Soc. Nephrol. 2014, 25:2689.
6. Ortiz A., Justo P., Sanz A., Lorz C., Egido J. Targeting apoptosis in acute tubular injury. Biochem. Pharmacol. 2003, 66:1589.
7. Wan F., Lenardo M.J. Specification of DNA binding activity of NF-kappaB proteins. Cold Spring Harb. Perspect. Biol. 2009, 1:a000067.
8. Basak S., Hoffmann A. Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev. 2008, 19:187.
9. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344.
10. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007, 8:49.
11. Sanz A.B., Sanchez-Nino M.D., Ramos A.M., Moreno J.A., Santamaria B., Ruiz-Ortega M., Egido J., Ortiz A. NF-kappaB in renal inflammation. J. Am. Soc. Nephrol. 2010, 21:1254.
12. Poveda J., Tabara L.C., Fernandez-Fernandez B., Martin-Cleary C., Sanz A.B., Selgas R., Ortiz A., Sanchez-Nino M.D. TWEAK/Fn14 and non-canonical NF-kappaB signaling in kidney disease. Front. Immunol. 2013, 4:447.
13. Kitamura H., Kanehira K., Okita K., Morimatsu M., Saito M. MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-production. FEBS Lett. 2000, 485:53.
14. Haruta H., Kato A., Todokoro K. Isolation of a novel interleukin-1-inducible nuclear protein bearing ankyrin-repeat motifs. J. Biol. Chem. 2001, 276:12485.
15. Yamazaki S., Muta T., Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 2001, 276:27657.
16. Sparna T., Retey J., Schmich K., Albrecht U., Naumann K., Gretz N., Fischer H.P., Bode J.G., Merfort I. Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes. BMC Genomics 2010, 11:226.
17. Dhamija S., Winzen R., Doerrie A., Behrens G., Kuehne N., Schauerte C., Neumann E., Dittrich-Breiholz O., Kracht M., Holtmann H. Interleukin-17 (IL-17) and IL-activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1. J. Biol. Chem. 2013, 288:19250.
18. Nogai H., Wenzel S.S., Hailfinger S., Grau M., Kaergel E., Seitz V., Wollert-Wulf B., Pfeifer M., Wolf A., Frick M., Dietze K., Madle H., Tzankov A., Hummel M., Dorken B., Scheidereit C., Janz M., Lenz P., Thome M., Lenz G. IkappaB-zeta controls the constitutive NF-kappaB target gene network and survival of ABC DLBCL. Blood 2013, 122:2242.
19. Trinh D.V., Zhu N., Farhang G., Kim B.J., Huxford T. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA. J. Mol. Biol. 2008, 379:122.
20. Matsuo S., Yamazaki S., Takeshige K., Muta T. Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation. Biochem. J. 2007, 405:605.
21. Totzke G., Essmann F., Pohlmann S., Lindenblatt C., Janicke R.U., Schulze-Osthoff K. A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. J. Biol. Chem. 2006, 281:12645.
22. Motoyama M., Yamazaki S., Eto-Kimura A., Takeshige K., Muta T. Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein. J. Biol. Chem. 2005, 280:7444.
23. Israel A., Le B.O., Hatat D., Piette J., Kieran M., Logeat F., Wallach D., Fellous M., Kourilsky P. TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J. 1989, 8:3793.
24. Schmitz M.L., Baeuerle P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 1991, 10:3805.
25. Kang S.M., Tran A.C., Grilli M., Lenardo M.J. NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 1992, 256:1452.
26. Brown A.M., Linhoff M.W., Stein B., Wright K.L., Baldwin A.S., Basta P.V., Ting J.P. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits. Mol. Cell. Biol. 1994, 14:2926.
27. Yamazaki S., Matsuo S., Muta T., Yamamoto M., Akira S., Takeshige K. Gene-specific requirement of a nuclear protein, IkappaB-zeta, for promoter association of inflammatory transcription regulators. J. Biol. Chem. 2008, 283:32404.
28. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., Kaisho T., Kuwata H., Takeuchi O., Takeshige K., Saitoh T., Yamaoka S., Yamamoto N., Yamamoto S., Muta T., Takeda K., Akira S. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 2004, 430:218.
29. Hildebrand D.G., Alexander E., Horber S., Lehle S., Obermayer K., Munck N.A., Rothfuss O., Frick J.S., Morimatsu M., Schmitz I., Roth J., Ehrchen J.M., Essmann F., Schulze-Osthoff K. IkappaBzeta is a transcriptional key regulator of CCL2/MCP-1. J. Immunol. 2013, 190:4812.
30. Kannan Y., Yu J., Raices R.M., Seshadri S., Wei M., Caligiuri M.A., Wewers M.D. IkappaBzeta augments IL-12- and IL-18-mediated IFN-gamma production in human NK cells. Blood 2011, 117:2855.
31. Okamoto K., Iwai Y., Oh-Hora M., Yamamoto M., Morio T., Aoki K., Ohya K., Jetten A.M., Akira S., Muta T., Takayanagi H. IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature 2010, 464:1381.
32. Shiina T., Konno A., Oonuma T., Kitamura H., Imaoka K., Takeda N., Todokoro K., Morimatsu M. Targeted disruption of MAIL, a nuclear IkappaB protein, leads to severe atopic dermatitis-like disease. J. Biol. Chem. 2004, 279:55493.
33. Haverty T.P., Kelly C.J., Hines W.H., Amenta P.S., Watanabe M., Harper R.A., Kefalides N.A., Neilson E.G. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J. Cell Biol. 1988, 107:1359.
34. Justo P., Sanz A.B., Sanchez-Nino M.D., Winkles J.A., Lorz C., Egido J., Ortiz A. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int. 2006, 70:1750.
35. Sanz A.B., Justo P., Sanchez-Nino M.D., Blanco-Colio L.M., Winkles J.A., Kreztler M., Jakubowski A., Blanco J., Egido J., Ruiz-Ortega M., Ortiz A. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J. Am. Soc. Nephrol. 2008, 19:695.
36. Sanchez-Nino M.D., Sanz A.B., Sanchez-Lopez E., Ruiz-Ortega M., Benito-Martin A., Saleem M.A., Mathieson P.W., Mezzano S., Egido J., Ortiz A. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab. Investig. 2012, 92:32.
37. Poveda J., Sanchez-Nino M.D., Glorieux G., Sanz A.B., Egido J., Vanholder R., Ortiz A. p-cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells. Nephrol. Dial. Transplant. 2014, 29:56.
38. Sanz A.B., Sanchez-Nino M.D., Izquierdo M.C., Jakubowski A., Justo P., Blanco-Colio L.M., Ruiz-Ortega M., Selgas R., Egido J., Ortiz A. TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21. PLoS ONE 2010, 5.
39. Wen X., Peng Z., Li Y., Wang H., Bishop J.V., Chedwick L.R., Singbartl K., Kellum J.A. One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice. Nephrol. Dial. Transplant. 2012, 27:3100.
40. Sanchez-Nino M.D., Poveda J., Sanz A.B., Mezzano S., Carrasco S., Fernandez-Fernandez B., Burkly L.C., Nair V., Kretzler M., Hodgin J.B., Ruiz-Ortega M., Selgas R., Egido J., Ortiz A. Fn14 in podocytes and proteinuric kidney disease. Biochim. Biophys. Acta 2013, 1832:2232.
41. Izquierdo M.C., Sanz A.B., Mezzano S., Blanco J., Carrasco S., Sanchez-Nino M.D., Benito-Martin A., Ruiz-Ortega M., Egido J., Ortiz A. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation. Kidney Int. 2012, 81:1098.
42. Moreno J.A., Izquierdo M.C., Sanchez-Nino M.D., Suarez-Alvarez B., Lopez-Larrea C., Jakubowski A., Blanco J., Ramirez R., Selgas R., Ruiz-Ortega M., Egido J., Ortiz A., Sanz A.B. The inflammatory cytokines TWEAK and TNFalpha reduce renal klotho expression through NFkappaB. J. Am. Soc. Nephrol. 2011, 22:1315.
43. Sanz A.B., Izquierdo M.C., Sanchez-Nino M.D., Ucero A.C., Egido J., Ruiz-Ortega M., Ramos A.M., Putterman C., Ortiz A. TWEAK and the progression of renal disease: clinical translation. Nephrol. Dial. Transplant. 2014, 29(Suppl. 1):i54-i62.
44. Lorz C., Ortiz A., Justo P., Gonzalez-Cuadrado S., Duque N., Gomez-Guerrero C., Egido J. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J. Am. Soc. Nephrol. 2000, 11:1266.
45. Sanz A.B., Sanchez-Nino M.D., Izquierdo M.C., Jakubowski A., Justo P., Blanco-Colio L.M., Ruiz-Ortega M., Egido J., Ortiz A. Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia. J. Cell. Mol. Med. 2009, 13:3329.
46. Ortiz A., Bustos C., Alonso J., Alcazar R., Lopez-Armada M.J., Plaza J.J., Gonzalez E., Egido J. Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv. Nephrol. Necker Hosp. 1995, 24:53.
47. Ito T., Morimatsu M., Oonuma T., Shiina T., Kitamura H., Syuto B. Transcriptional regulation of the MAIL gene in LPS-stimulated RAW264 mouse macrophages. Gene 2004, 342:137.
48. Izquierdo M.C., Perez-Gomez M.V., Sanchez-Nino M.D., Sanz A.B., Ruiz-Andres O., Poveda J., Moreno J.A., Egido J., Ortiz A. Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol. Dial. Transplant. 2012, 27(Suppl. 4).
49. Zhou L., Li Y., Zhou D., Tan R.J., Liu Y. Loss of Klotho contributes to kidney injury by derepression of Wnt/beta-catenin signaling. J. Am. Soc. Nephrol. 2013, 24:771.
50. Carracedo J., Buendia P., Merino A., Madueno J.A., Peralbo E., Ortiz A., Martin-Malo A., Aljama P., Rodriguez M., Ramirez R. Klotho modulates the stress response in human senescent endothelial cells. Mech. Ageing Dev. 2012, 133:647.
51. Kayama H., Ramirez-Carrozzi V.R., Yamamoto M., Mizutani T., Kuwata H., Iba H., Matsumoto M., Honda K., Smale S.T., Takeda K. Class-specific regulation of pro-inflammatory genes by MyD88 pathways and IkappaBzeta. J. Biol. Chem. 2008, 283:12468.
52. Yamazaki S., Muta T., Matsuo S., Takeshige K. Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/interleukin-receptor is mediated by mRNA stabilization. J. Biol. Chem. 2005, 280:1678.